Takeda Pharma Files 6-K for June 2024

TL;DR

Takeda filed its monthly 6-K, confirming its Tokyo HQ and 20-F filing status.

AI Summary

Takeda Pharmaceutical Company Limited filed a Form 6-K on June 11, 2024, to report information as a foreign private issuer for the month of June 2024. The filing indicates Takeda's principal executive offices are located at 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan. Takeda confirms it files annual reports under Form 20-F.

Why It Matters

This filing provides routine updates for Takeda Pharmaceutical as a foreign private issuer, ensuring compliance with SEC reporting requirements for international companies.

Risk Assessment

Risk Level: low — This is a routine administrative filing by a large, established company and does not contain new financial or operational information that would typically indicate significant risk.

Key Players & Entities

• Takeda Pharmaceutical Company Limited (company) — Registrant
• 0001395064-24-000068 (filing_id) — Accession Number
• 20240611 (date) — Filing Date
• 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo 103-8668 Japan (address) — Principal Executive Offices
• 001-38757 (company_id) — Commission File Number

FAQ

Filing Documents

• form6k_061124.htm (6-K) — 36KB
• 0001395064-24-000068.txt ( ) — 37KB

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TAKEDA PHARMACEUTICAL COMPANY LIMITED Date June 11, 2024 By s Norimasa Takeda Norimasa Takeda Chief Accounting Officer and Corporate Controller News Release Notice Concerning Issuance of New Shares and Disposal of Treasury Shares under the Long-Term Incentive Plan for Company Group Employees Outside of Japan Osaka, JAPAN, June 11, 2024 – Takeda Pharmaceutical Company Limited ("Company") today announced that it decided on the issuance of new shares and disposal of treasury shares under the Long Term Incentive Plan ("LTIP") for the Company Group employees outside of Japan, as outlined below ("Issuance of Shares"). 1. Outline of Issuance of Shares (1) Payment date July 8, 2024 (2) Type and number of shares to be disposed of 15,905,936 ordinary shares of the Company, which is the total of the following (i) 8,578,474 new shares and (ii) 7,327,462 treasury shares. (3) Issuance and disposal price 4,241 yen per share (4) Total value of shares to be disposed of 67,457,074,576 yen (5) Planned allottee Employees of the Company and the Company's subsidiaries numbering 10,954 persons 15,905,936 shares (6) Other The Company will dispose of treasury shares and issue new shares on the condition that the shelf registration becomes effective and the shelf registration supplements are filed. Note If the total number of shares to be subscribed by the allottees does not reach the total number of shares in item (2) above, the Company will allot the treasury shares in advance of the new shares, and if there are any shares which are not subscribed by the allottees, the allotment of the said shares will be forfeited. 2. Purposes and reason for Issuance of Shares At the meeting of the Board of Directors held on June 24, 2020, the Company resolved to introduce

View Full Filing

View this 6-K filing on SEC EDGAR